PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
ConclusionPD-L1 expression in TILs,but not in tumor cells,was a poor prognostic factor in TNBC. These data provide further impetus for assessing immunotherapy in TNBC, in view of the clinical significance of the expression of PD-L1(SP142) in TNBC.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Melanoma | Non-Small Cell Lung Cancer | Pathology | Skin Cancer